Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PLCE stock price vs BMRN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BMRN's multiple
Needs BMRN P/S.
Implied fair value · at PLCE's multiple
Needs PLCE P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PLCE FY 2026 (ended Jan 31, 2026) · BMRN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
THE CHILDREN’S PLACE, INC. · implied price per share
Bear
-$30.32
Base
-$35.67
Bull
-$41.02
BIOMARIN PHARMACEUTICAL INC · implied price per share
Bear
$25.74
Base
$30.28
Bull
$34.82
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-3.34x
0.06x
Net debt / EBITDA
Leverage against operating earnings
-51.51x
-3.03x
Cash and equivalents
Liquid reserves on the balance sheet
$20.49M
$2.11B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABERCROMBIE & FITCH CO /DE/
PLCE vs ANF
FOOT LOCKER, INC.
PLCE vs FL
WOLVERINE WORLD WIDE INC /DE/
PLCE vs WWW
GAP INC
PLCE vs GAP
Sally Beauty Holdings, Inc.
PLCE vs SBH
TILLY'S, INC.
PLCE vs TLYS
VERTEX PHARMACEUTICALS INC / MA
PLCE vs VRTX
ALNYLAM PHARMACEUTICALS, INC.
PLCE vs ALNY
Sarepta Therapeutics, Inc.
PLCE vs SRPT
REGENXBIO Inc.
PLCE vs RGNX
IONIS PHARMACEUTICALS INC
PLCE vs IONS
PTC THERAPEUTICS, INC.
PLCE vs PTCT
$180.90M
$347.22M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
